Matthew Emmens Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew Emmens.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew Emmens. Matthew Emmens is a CEO & President in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and a Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and an Executive Chairman in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
Address: C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST CAMBRIDGE 02139 MA
Companies in which Matthew Emmens is an Insider
VERTEX PHARMACEUTICALS INC / MA
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew Emmens: Director, Executive Chairman, CEO & President
Holdings: 211,601 shares
Current Value: $18,375,431
Latest Transaction: Jun 01 2012
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew Emmens
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Director | Option Exercise | A | 59.55 | 20,000 | 1,191,000 | 20,000 | |
| Feb 07 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Executive Chairman | Sell | S | 38.08 | 40,600 | 1,546,048 | 211,601 | 252.2 K to 211.6 K (-16.10 %) |
| Feb 07 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Executive Chairman | Sell | S | 37.11 | 12,900 | 478,719 | 252,201 | 265.1 K to 252.2 K (-4.87 %) |
| Feb 07 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Executive Chairman | Sell | S | 36.39 | 2,500 | 90,975 | 265,101 | 267.6 K to 265.1 K (-0.93 %) |
| Feb 06 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Executive Chairman | Option Exercise | A | 37.86 | 236,000 | 8,934,960 | 236,000 | |
| Feb 06 2012 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | Executive Chairman | Grant | A | 0.01 | 47,201 | 472 | 267,601 | 220.4 K to 267.6 K (+21.42 %) |
| Jul 14 2011 | VRTX | VERTEX PHARMACEUTI ... | Emmens Matthew | CEO & President | Option Exercise | A | 51.75 | 118,000 | 6,106,500 | 118,000 |